A Prospective, Safety and Efficacy Cohort Study of Elevate Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse Repair
A study for women with Pelvic Organ Prolapse who require surgical treatment using Elevate Anterior and Apical Prolapse repair system
Sponsor: Astora Women's Health
Enrolling: Male and Female Patients
IRB Number: AAAQ4553
Contact: Cara Grimes: 212-305-1107 / clg2173@columbia.edu
Additional Study Information: The objective of this research study is to compare the treatment success rates and safety of two surgical treatment options: Native Tissue Repair and the Elevate Prolapse Repair System. You maychoose to participate in this research when you and your doctor have determined which surgical treatment option is right for you. The Elevate Prolapse Repair System is an FDA-cleared medicaldevice which has been successfully used since 2009 as a treatment to repair pelvic organ prolapse in women. The FDA is requesting post market studies to compare these two treatment options.
This study is closed
Investigator
Cara Grimes, MD, FACOG
Do You Qualify?
Do you suffer from Pelvic Organ Prolapse and require surgical treatment? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Cara Grimes
clg2173@columbia.edu
212-305-1107